Group B Streptococcus and escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis

Pediatric Infectious Disease Journal

Volumn 32, Issue 3, 2013, Pages 208-212

  Bauserman, Melissa S ^a   Laughon, Matthew M ^a   Hornik, Christoph P ^b   Smith, P Brian ^b   Benjamin Jr , Daniel K ^b   Clark, Reese H ^c   Engmann, Cyril ^a   Cohen Wolkowiez, Michael ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Pediatrix Obstetrix Center for Research and Education   (United States)

Author keywords

Escherichia coli; Group B Streptococcus; Infant; Infection; Sepsis

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BLOODSTREAM INFECTION; CEREBROSPINAL FLUID CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTRAPARTUM CARE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTICENTER STUDY; NEWBORN; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STREPTOCOCCUS AGALACTIAE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BLOOD; CEREBROSPINAL FLUID; COHORT STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; URINE;

EID: 84876297075     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318275058a     Document Type: Article

References (28)

1. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol. 2003;27:293-301.
2. Stoll BJ, Hansen NI, Adams-Chapman I, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neurode-velopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357-2365.
3. Schrag SJ, Stoll BJ. Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J. 2006;25:939-940.
4. Bizzarro MJ, Raskind C, Baltimore RS, et al. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics. 2005;116:595-602.
5. Stoll BJ, Hansen NI, Sanchez PJ, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127:817-826.
6. Baker CJ, Byington CL, Polin RA. Policy statement: recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics. 2011;128:611-616.
7. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30:937-941.
8. Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360:2626-2636.
9. Goins WP, Talbot TR, Schaffner W, et al. Adherence to perinatal group B streptococcal prevention guidelines. Obstet Gynecol. 2010;115:1217-1224.
10. Centers for Disease Control and Prevention. Early-onset and late-onset neonatal group B streptococcal disease-United States, 1996-2004. MMWR Morb Mortal Wkly Rep. 2005;54:1205-1208.
11. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
12. Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347:240-247.
13. Lukacs SL, Schoendorf KC, Schuchat A. Trends in sepsis-related neonatal mortality in the United States, 1985-1998. Pediatr Infect Dis J. 2004;23:599-603.
14. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115:1240-1246.
15. Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations-United States, 2003-2005. MMWR Morb Mortal Wkly Rep. 2007;56:701-705.
16. Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis. 2003;3:201-213.
17. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N EnglJ Med. 2000;342:15-20.
18. Alarcon A, Pena P, Salas S, et al. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J. 2004;23:295-299.
19. Phares CR, Lynfield R, Farley MM, et al.; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299:2056-2065.
20. Bizzarro MJ, Dembry LM, Baltimore RS, et al. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008;121:689-696.
21. Ecker KL, DonohuePK, Kim KS, et al. The impact of group B Streptococcus prophylaxis on late-onset neonatal infections [published online ahead of print June 14, 2012]. J Perinatol. doi: 10.1038/jp.2012.76.
22. Nowell L, Moran C, Smith PB, et al. Prevalence of renal anomalies after urinary tract infections in hospitalized infants less than 2 months of age. J Perinatol. 2010;30:281-285.
23. Bauer S, Eliakim A, Pomeranz A, et al. Urinary tract infection in very low birth weight preterm infants. Pediatr Infect Dis J. 2003;22:426-430.
24. Jordan HT, Farley MM, Craig A, et al.; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: amultistate, population-based analysis. Pediatr Infect Dis J. 2008;27:1057-1064.
25. Glasgow TS, Young PC, Wallin J, et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants. Pediatrics. 2005;116:696-702.
26. Stoll BJ, Hansen NI, Higgins RD, et al.; National Institute of Child Health and Human Development. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J. 2005;24:635-639.
27. Cotten CM, McDonald S, Stoll B, et al.; National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118:717-722.
28. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and metaanalysis. Lancet. 2012;379:547-556.